← FDA DRUG APPROVALS

FDA ANDA · ANDA070617

VERAPAMIL HYDROCHLORIDE

Sponsor: LUITPOLD

APPLICATION
ANDA070617
TYPE
ANDA
ORIGINAL APPROVAL
1985-11-12
LATEST ACTION
2002-04-19
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

VERAPAMIL HYDROCHLORIDEDiscontinued
VERAPAMIL HYDROCHLORIDE 2.5MG/ML · INJECTABLE · INJECTION

Approval history

2002-04-19Manufacturing (CMC) · Supplement 14AP
1997-08-13Manufacturing (CMC) · Supplement 13AP
1997-02-27Manufacturing (CMC) · Supplement 11AP
1997-02-27Manufacturing (CMC) · Supplement 12AP
1996-02-28Manufacturing (CMC) · Supplement 10AP
1995-12-13Labeling · Supplement 9AP
1994-07-14Manufacturing (CMC) · Supplement 8AP
1993-05-28Manufacturing (CMC) · Supplement 6AP
1992-05-21Labeling · Supplement 7AP
1988-10-13Labeling · Supplement 5AP
1987-06-12Labeling · Supplement 4AP
1986-03-21Labeling · Supplement 3AP
1986-03-21Manufacturing (CMC) · Supplement 1AP
1986-03-21Manufacturing (CMC) · Supplement 2AP
1985-11-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →